Why Attend the Industry Dedicated Phage Summit

Discover how leading innovators are translating bacteriophage science into safe, scalable and commercially viable therapies.

Across three days of data-driven presentations, interactive discussions and high-value networking, you will gain the insights, strategies and connections needed to overcome today’s biggest barriers in clinical development, regulation, manufacturing and investment. Join the only global meeting built for the entire phage ecosystem and play your part in bringing precision antibacterial solutions to patients worldwide.

12

Unmissable Event Highlights

Tackle Industry Bottlenecks Head-On

Gain practical strategies to overcome the real challenges in phage development, from clinical trial design and regulatory navigation to GMP manufacturing and commercial readiness.

Experience Real-World Case Studies

Hear from leading phage developers including Armata Therapeutics, Technophage, and Queen Astrid Military Hospital as they share clinical data, compassionate-use frameworks, and lessons learned from patient delivery.

Unlock Cross-Sector Applications

Explore how phage innovation is expanding beyond human health into animal, agricultural and environmental sectors to meet the global need for sustainable antibacterial solutions.

Leverage Next-Generation Modalities

Discover the potential of engineered and CRISPR-enhanced phages, lysins and synthetic biology to boost precision, scalability and therapeutic success.

Build Partnerships That Accelerate Progress

Connect with CEOs, professors and scientific leaders from across biotech, pharma, policy and academia to form the collaborations shaping the next wave of antibacterial breakthroughs.

Full Event Guide

  • 18+ Speakers, bringing you critical insights from key companies including Armata Therapeutics, Technophage, SNIPR Biome and more
  • 80% C-Suite or Equivalent Speakers, ensuring you are gaining the freshest data and optimized clinical trial strategies, powering your pipeline with the expertise of others
  • 18 Case Studies, spanning investment, regulation, manufacturing and other critical industry
  • 10 Networking hours, ensuring you have time to connect and discuss with leaders from the field, and ensuring you are a part of the conversation as the future of phages is dictated
  • 3 Panel Discussions, giving you opportunities to hear open and honest opinions from phage developers, manufacturers, policy shapers and academics – and chance for you to ask any burning questions
ee7 brochure image

Attending Companies Include

2 (1)
Explore the Agenda

Hear the latest breakthroughs driving bacteriophage therapies to patients and gain practical insights through data-driven talks, panels and roundtables.

20
Partner With Us

Position your brand at the centre of the phage ecosystem and connect with companies shaping the future of antibacterial innovation.

3 (1)
Join Biopharma Experts

Be part of the global phage community advancing research, regulation and commercialisation while making valuable connections across every stage of development.